Quadramet
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Quadramet, covering 2007-12-21 to 2025-11-06. Get the full timeline:
Most recent: EMA Authorised: Quadramet (samarium (153Sm) lexidronam pentasodium) — CIS bio international